Relation of Polymorphism of the Histidine Decarboxylase Gene to Chronic Heart Failure in Han Chinese.

Gong-Hao He,Wen-Ke Cai,Jing-Ru Meng,Xue Ma,Fan Zhang,Jun Lu,Gui-Li Xu
DOI: https://doi.org/10.1016/j.amjcard.2015.02.062
IF: 3.133
2015-01-01
The American Journal of Cardiology
Abstract:Histidine decarboxylase (HDC) is a key determinant of the levels of endogenous histamine that has long been recognized to play important pathophysiological roles during development of chronic heart failure (CHF). Meanwhile, certain genetic variants in HDC gene were reported to affect the function of HDC and associated with histamine-related diseases. However, the relation between polymorphisms of HDC gene and CHF risk remains unclear. This study aims to investigate the associations between 2 nonsynonymous HDC polymorphisms (rs17740607 and rs2073440) and CHF. We designed a 2-stage case control study, in which we genotyped 439 patients with CHF and 467 healthy controls recruited in Xi'an, China, and replicated this study in 413 patients with CHF and 452 healthy subjects in Kunming, China. We also performed in vitro experiments to further validate the functional consequences of variants positively associated with CHF. The rs17740607 polymorphism showed replicated associations with all-cause CHF according to genotype and allele distribution and also under a dominant and additive genetic model after adjusted for traditional cardiovascular-related factors. Functional experiments further demonstrated that rs17740607 polymorphism decreased the HDC activity. In conclusion, HDC rs17740607 polymorphism is at least a partial loss-of-function variant and acts as a protective factor against CHF, which provides novel highlights for investigating the contribution of CHF. (C) 2015 Elsevier Inc. All rights reserved.
What problem does this paper attempt to address?